Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
MICROBIAL IMMUNOLOGY

Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals

John P. Bannantine, Avery L. Paulson, Ofelia Chacon, Robert J. Fenton, Denise K. Zinniel, David S. McVey, David R. Smith, Charles J. Czuprynski, Raúl G. Barletta
John P. Bannantine
1Bacterial Diseases of Livestock Research Unit, USDA ARS National Animal Disease Center, Ames, Iowa 50010
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avery L. Paulson
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ofelia Chacon
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Fenton
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise K. Zinniel
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David S. McVey
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Smith
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles J. Czuprynski
3Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin—Madison, Madison, Wisconsin 53706
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raúl G. Barletta
2School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rbarletta@unl.edu
DOI: 10.1128/CVI.00297-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Genomic map of PE, PPE, and UPF genes in M. avium subsp. paratuberculosis K-10 (MAP). Genes encoding PE (shown as bars inside of the circular chromosome), PPE (bars crossing the circular chromosome), and UPF (bars outside the circle) protein family members are shown. No PGRS protein-coding sequences were found. (Inset) MAP1152-MAP1156 genomic region, indicating genes encoding PPE proteins MAP1152, MAP1153, and MAP1155 (black boxes), UPF protein MAP1156 (gray box), hypothetical protein MAP1154 (dark patterned box), and MAP1150c and MAP1151c (light patterned boxes). Arrowed boxes indicate the direction of transcription.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    SDS-PAGE and immunoblot analysis of recombinant M. avium subsp. paratuberculosis MAP1152 and MAP1156 proteins. Shown is a 12% SDS-PAGE gel, stained with GelCode blue, along with three corresponding immunoblots containing purified recombinant fusion proteins. Antibody or serum samples used to probe the immunoblot are indicated beneath the panels: MBP MAb, monoclonal antibody against the maltose-binding protein; mouse 160, serum derived from a mouse immunized with live M. avium subsp. paratuberculosis cells; rabbit 273, serum derived from a rabbit immunized with live M. avium subsp. paratuberculosis cells. Size standards, reported in kDa, are indicated to the left. Assignments for the gel and blots were as follows: lane 1, protein size standards; lane 2, MAP1152; lane 3, MAP1156; lane 4, LacZ.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Western blot analysis of antibody responses to MAP1152 and MAP1156 in naturally infected cattle. Immunoblots containing MAP1152 and MAP1156 were probed with sera from five cows (183, 2075, 84, 805, and 45) naturally infected with M. avium subsp. paratuberculosis (A) or from two additional cows experimentally infected with M. avium or M. bovis (B). Size standards, reported in kDa, are indicated to the left. Assignments for the blots were as follows: lane 1, protein size standards; lane 2, MAP1152; lane 3, MAP1156; lane 4, LacZ.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Western blot analysis of antibody responses to MAP1152 and MAP1156 during the course of JD. Immunoblots of MAP1152 (upper gel), MAP1156 (middle gel), and K-10 whole-cell extract (lower gel) were probed with serum samples withdrawn from a naturally infected cow (cow 47) at various times during the course of the experiment: lane 1, first bleed, subclinical infection; lane 2, 12 months after first bleed, borderline clinical/subclinical infection; lane 3, 26 months after first bleed, clinical infection; lane 4, 35 months after first bleed, advanced clinical infection; lane 5, anti-MBP monoclonal antibody control. Size standards (in kDa) are indicated to the left.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Seroreactivities of MAP1152 and MAP1156 recombinant proteins to infected and noninfected cattle. Antigen (0.010 mg) reactivity was evaluated by ELISA against sera from cattle naturally infected with M. avium subsp. paratuberculosis (filled bars) or sera from culture-negative cattle (open bars). Each serum sample was diluted 1:25 in Idexx dilution buffer. Each column represents mean absorbance (from triplicate measurements against LacZ; averaged from measurements on three different days in duplicate or triplicate for other antigens [see Table S2 of the supplemental material]) per antigen, ± standard errors of the means from noninfected cattle (left columns) or infected cattle (right columns), as evidenced from the original classification of serum samples. Significance levels are indicated as follows: *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Individual responses of serum samples from infected and noninfected cattle to recombinant antigens. Antigen (0.010 mg) reactivity was evaluated by ELISA against sera from cattle naturally infected with M. avium subsp. paratuberculosis and sera from culture-negative cattle. Each serum was diluted 1:25 in Idexx dilution buffer. Each column represents mean absorbance (triplicate measurements against LacZ; average measurements on three different days in duplicate or triplicate for other antigens, as indicated in Table S2 of the supplemental material) per antigen, ± standard errors of the means from noninfected (−) or infected (+) cattle, as evidenced from the original classification of serum samples. The reaction to each antigen is indicated (see inset for pattern key).

Tables

  • Figures
  • Additional Files
  • TABLE 1.

    Cattle serum samples used in the study

    Serum sampleOriginal classification (Idexx test)Type of infectionSource
    Cow 183+Natural (JD)NADCa
    Cow 2075+Natural (JD)NADC
    Cow 184+Natural (JD)NADC
    Cow 805+Natural (JD)NADC
    Cow 45+Natural (JD)NADC
    Cow 193−Experimental, with M. avium hominissiusNADC
    Cow 2291−Experimental, with M. bovis strain 95-1315NADC
    Cow 47+Natural (JD)NADC
    Positive controlb+Natural (JD)Idexx Laboratories
    EDNA+Natural (JD)NADC
    Cow 308+Natural (JD)NADC
    2010-07+Natural (JD)Nebraska dairyc
    Negative controld−NoneIdexx Laboratories
    J53-90−NoneNebraska beef herdc
    Cow 559−NoneNADC
    3438-08−NoneNebraska dairyc
    • ↵a NADC, National Animal Disease Center, Ames, IA.

    • ↵b Positive-control serum provided with the Idexx kit, derived from a single naturally infected Holstein cow (Idexx Technical Service).

    • ↵c Dairy or beef cattle of the University of Nebraska Lincoln Veterinary Diagnostic Center, Lincoln, NE.

    • ↵d Negative-control serum provided with the Idexx kit, derived from a single Holstein cow residing in a herd that tested negative for paratuberculosis by whole-herd testing over multiple years (Idexx Technical Service).

  • TABLE 2.

    Characterizations of ORFs MAP1152 to MAP1156

    ORFSize (no. of aa, mass)aH37Rv homologb/E-valuecDomain, motifa,cComment(s)d
    MAP1152416, 40.7Rv1808 (PPE32)/8.0 E−78PPE, GxxSVPxxWThree MH
    MAP1153454, 45.7Rv1809 (PPE33)/1.0 E−84PPE, GxxSVPxxWCoding sequence starts 7 bp downstream from MAP1152; three MH
    MAP1154117, 11.7Rv1810/8.0 E−19DUF732 superfamilyHypothetical protein; no MH
    MAP1155320, 32.2Rv1807 (PPE31)/4.0 E−24PPE, GxxSVPxxWAttenuating mutation in M. tuberculosis homolog (49); two MH
    MAP1156464, 50.6Rv1425/0.0UPF0089M. tuberculosis homolog encodes enzyme with low TGS activity (16); possibly one MH
    • ↵a Data are based on National Center for Biotechnology Information (NCBI) database output. Sizes are reported as the number of amino acids (aa) and as molecular mass (in kilodaltons).

    • ↵b Data entries based on the Pfam database (http://pfam.sanger.ac.uk/family). Most homologous M. tuberculosis proteins are not necessarily orthologs (22).

    • ↵c E-values (determined using the Blastp suite) are formatted as described in the BLAST help manual (http://www.ncbi.nlm.nih.gov/blast/blast_help.shtml).

    • ↵d MH, membrane helices (determined via the PredictProtein server [http://www.predictprotein.org] for protein analysis [PHDhtm output]).

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 - Table S1. Density data determined using Western blotting.
      PDF file, 7K.
    • Supplemental file 2 - Table S2. ELISA absorbance data with descriptive statistics.
      PDF file, 73K.
    • Supplemental file 3 - Table S3. Mixed-model regression analysis of mean absorbance differences between seropositive and seronegative samples.
      PDF file, 11K.
    • Supplemental file 4 - Table S4. Serum-antigen pair seroreactivity determined using GLIMMIX.
      PDF file, 96K.
    • Supplemental file 5 - Table S5. Percent identity and similarity of MAP1152 and MAP1156 with closest M. avium104, M. bovis, and M. avium subsp. paratuberculosis orthologs and paralogs.
      PDF file, 15K.
PreviousNext
Back to top
Download PDF
Citation Tools
Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals
John P. Bannantine, Avery L. Paulson, Ofelia Chacon, Robert J. Fenton, Denise K. Zinniel, David S. McVey, David R. Smith, Charles J. Czuprynski, Raúl G. Barletta
Clinical and Vaccine Immunology Jan 2011, 18 (1) 105-112; DOI: 10.1128/CVI.00297-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Immunogenicity and Reactivity of Novel Mycobacterium avium subsp. paratuberculosis PPE MAP1152 and Conserved MAP1156 Proteins with Sera from Experimentally and Naturally Infected Animals
John P. Bannantine, Avery L. Paulson, Ofelia Chacon, Robert J. Fenton, Denise K. Zinniel, David S. McVey, David R. Smith, Charles J. Czuprynski, Raúl G. Barletta
Clinical and Vaccine Immunology Jan 2011, 18 (1) 105-112; DOI: 10.1128/CVI.00297-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X